ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology Announces ClinCheck® Live Plan That Automates Doctor-Ready Initial Invisalign® Treatment Plan in Minutes

ClinCheck Live Plan represents a major technological milestone in the Align™ Digital Platform, that can reduce the Invisalign treatment planning cycle from days to minutes and lead to patients starting treatment faster.

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced ClinCheck® Live Plan, a new feature in its Invisalign® digital treatment planning that automates the generation of initial doctor-ready treatment plans within 15 minutes. This advancement represents a major technological milestone in the Align™ Digital Platform, that can reduce the Invisalign treatment planning cycle from days to minutes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029924215/en/

ClinCheck® Live Plan represents a major technological milestone in the Align™ Digital Platform, that can reduce the Invisalign treatment planning cycle from days to minutes and lead to patients starting treatment faster.

ClinCheck® Live Plan represents a major technological milestone in the Align™ Digital Platform, that can reduce the Invisalign treatment planning cycle from days to minutes and lead to patients starting treatment faster.

ClinCheck Live Plan is built on Align’s proprietary data and algorithms, derived from decades of research and development and the experience of doctors who have treated more than 21 million Invisalign patients worldwide.

With ClinCheck Live Plan, doctors have the option to treatment plan in the moment and can receive a fully customized initial ClinCheck® treatment plan about 15 minutes after submitting an eligible case with Flex Rx. Doctors then have the option to review proposed tooth movements and approve a case while the patient is still in the office. This can enable the doctor to receive and approve the treatment plan faster, which can lead to the patient starting Invisalign treatment faster -- ultimately increasing office efficiency and improving the patient experience.

After an Invisalign doctor submits a new case with an iTero® intraoral scan and a completed Flex Rx prescription, the ClinCheck Live Plan system automatically applies the doctor’s pre-configured clinical preferences (such as an Invisalign® Personalized Plan or another preferences template) to create a detailed 3D plan. A series of quality checks then verify the treatment plan before it is returned to the doctor for review, in about 15 minutes.

“ClinCheck Live Plan marks a significant point in Align’s multi-year initiative to reimagine the Invisalign digital treatment planning experience, with the aim of improving practice growth and efficiency -- giving more time back to doctors,” said Sreelakshmi Kolli, executive vice president, chief product and digital officer. “This latest feature of the ClinCheck® signature experience represents the realization of a long-term vision to enable personalized treatment planning in minutes.”

Over the past few years, Align has introduced a range of new treatment planning tools and automation to enhance consistency, doctor control, and speed in treatment planning. To that end, Align continues to make great progress in automation and ML/AI-powered technologies that are the foundation of our next-generation treatment planning offerings.

Ms. Kolli added: “I’m excited by our continued progress and excited by the measurable impact we are beginning to see with treatment quality, practice workflow efficiency and doctor and patient experiences. The use of Invisalign Flex RX has doubled every year and to date, over 1 million Invisalign cases have been submitted through Flex Rx for personalized treatment plans.”

ClinCheck treatment planning innovations have included:

2020-2022: The launch of cloud-based ClinCheck® Pro 6.0 software and automated Invisalign® Personalized Plan templates.

2022: The introduction of the one-page Flex Rx prescription form for workflow simplification and ClinCheck Live Update for 3D controls for real-time doctor modifications

2024: The addition of Plan Editor, which gave doctors direct control to modify treatment approach in real-time.

Availability

Align plans to initiate the global roll-out of ClinCheck Live Plan in Q1 2026. Invisalign trained doctors who use the ClinCheck signature experience with a preferences template and the Flex Rx submission form will have access to ClinCheck Live Plan for eligible products as it becomes available in their region. The launch will be supported by comprehensive training resources, including webinars and how-to guides.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 291 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 21.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.20
-4.90 (-1.97%)
AAPL  273.47
-1.78 (-0.65%)
AMD  258.92
+21.40 (9.01%)
BAC  54.11
+0.48 (0.90%)
GOOG  287.45
-4.29 (-1.47%)
META  609.01
-18.07 (-2.88%)
MSFT  511.14
+2.46 (0.48%)
NVDA  193.80
+0.64 (0.33%)
ORCL  226.99
-9.16 (-3.88%)
TSLA  430.60
-9.02 (-2.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.